Development bank accused of lending millions to companies allegedly linked to forced labor in Xinjiang localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.
Extensive cooperation across warehousing, domestic distribution, international transports and logistics
In support of Chinese pharma customers access to international markets, leveraging Kuehne+Nagel s global pharma network
Further strengthens Kuehne+Nagel s presence in China
Kuehne+Nagel announces a strategic partnership with Jointown, China s largest non-state-owned pharmaceutical distribution company, to accelerate its footprint in pharma and healthcare logistics in China.
As one of the leading logistics providers in the world, Kuehne+Nagel has been especially focused on developing pharma & healthcare expertise for the past decade. The partnership with Jointown now affords access to their fullyGxP-compliant, in-country storage and distribution network, enabling Kuehne+Nagel to comply with the highly-regulated Chinese pharma & healthcare sector.
Kuehne + Nagel goes after China pharma logistics
Partnership with Jointown boosts K + N’s presence in China as more COVID-19 vaccines are approved A Kuehne + Nagel employee affixes a label to a medicine shipment. (Photo: K + N)
Two days after signing a definitive contract to acquire Hong Kong-based import/export facilitator Apex International Corp., mega-logistics services provider Kuehne + Nagel International AG struck a strategic partnership with Chinese pharmaceutical distributor Jointown, making good on recent plans to expand business in Asia.
Kuehne + Nagel, headquartered in Switzerland and number two in the world for logistics services based on gross revenue, said Wednesday it has entered into a partnership with China’s largest independent pharmaceutical distributor, accelerating its involvement in health care logistics in China.
BW Businessworld
Sinovac COVID-19 Vaccine Unit Struggles To Add New Hires As Holiday Nears
Sinovac has outsourced some procedures of filling vials and syringes and finishing packing the vaccine to partners in Indonesia and Brazil, allowing it to export bulk materials to lower production costs.
Photo Credit :
A Beijing unit of Sinovac Biotech manufacturing a COVID-19 vaccine said it is facing difficulties in finding staff to expand production because of surging local infections and the imminent Lunar New Year holiday.
Eleven people living in the Daxing district of the capital, Beijing, where Sinovac Life Science is based, were confirmed as COVID-19 patients between Sunday and Wednesday, forcing authorities to seal up some residential compounds and launch a mass testing scheme.